CONMED Corporation
CNMD
$34.49
-$0.28-0.81%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 13.83M | 16.74M | 2.86M | 21.42M | 6.04M |
| Total Depreciation and Amortization | 18.84M | 17.65M | 18.61M | 18.57M | 18.25M |
| Total Amortization of Deferred Charges | 1.28M | 2.74M | 1.28M | 1.39M | 1.44M |
| Total Other Non-Cash Items | 3.84M | 25.23M | 9.61M | 5.15M | 15.17M |
| Change in Net Operating Assets | -24.31M | -16.02M | 21.33M | -17.40M | 636.00K |
| Cash from Operations | 13.47M | 46.34M | 53.69M | 29.13M | 41.53M |
| Capital Expenditure | -2.89M | -5.11M | -5.19M | -5.73M | -3.78M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | 7.00M | -- | -- | -- | -- |
| Other Investing Activities | -- | -2.00M | 0.00 | 0.00 | 850.00K |
| Cash from Investing | 4.11M | -7.11M | -5.19M | -5.73M | -2.93M |
| Total Debt Issued | 180.00M | 187.00M | 167.00M | 200.67M | 166.00M |
| Total Debt Repaid | -155.00M | -207.00M | -196.00M | -211.67M | -180.59M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -37.02M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -6.19M | -6.19M | -6.19M | -6.18M |
| Other Financing Activities | -10.54M | -11.18M | -8.34M | -9.34M | -7.63M |
| Cash from Financing | -22.55M | -37.37M | -43.53M | -26.53M | -28.40M |
| Foreign Exchange rate Adjustments | -814.00K | 34.00K | 20.00K | 1.57M | 819.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.79M | 1.89M | 4.99M | -1.55M | 11.03M |